Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials
- PICCOLO, RAFFAELE
- PISCIONE, Federico
- Eitel, Ingo
- Iversen, Allan Zeeberg
- Gu, Youlan L
- Dominguez Rodriguez, Alberto
- de Smet, Bart J. G. L
- Mahmoud, Karim D
- Abreu Gonzalez, Pedro
- Thiele, Holger
DOIAbstract
In recent years, intracoronary bolus abciximab has emerged as an alternative to the standard intravenous route in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The aim of the current study was to perform an individual patient-level pooled analysis of randomised trials, comparing intracoronary versus intravenous abciximab bolus use in STEMI patients undergoing primary PCI
Add to ORKG